title: Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey?
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Juliano
authors.forename: Steve M
authors.initials: SM
authors.lastname: Taylor
authors.forename: Steven R
authors.initials: SR
authors.lastname: Meshnick
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D016133:Polymerase Chain Reaction / Q000379:methods*; D011739:Pyrimethamine / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013413:Sulfadoxine / Q000627:therapeutic use
chemical_list: D000962:Antimalarials; D013413:Sulfadoxine; D011739:Pyrimethamine